Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Ravi Ragbir. Photo: Andrew Lichtenstein / Getty

Immigrant rights activist Ravi Ragbir, with the backing of several pro-immigration rights groups, is suing the Immigration and Customs Enforcement in a New York federal district court. He's claiming that ICE violated his First Amendment rights by detaining him based only on his vocal activism.

Why it matters: There's expected to be an increase in ICE raids over the next year, with the Trump administration making it clear they intend to strictly enforce immigration laws. Ragbir and his lawyers are asking for an injunction that would protect Ragbir from deportation, but also would prevent ICE officials from arresting, detaining or deporting undocumented immigrants based on their protected political speech.

Background: Ragbir was suddenly arrested and detained by ICE on January 11th for 18 days, after which he was told to report for deportation on Saturday, February 10th. A federal court called his detention “unnecessarily cruel" and unconstitutional, alluding to possible First Amendment right violations.

"Like so many people who are living in this country under the threat of deportation, I know how important it is to raise our voices against the injustices in the system. This lawsuit is not just about me, it is about all of the members of our community who are speaking out in our struggle for immigrant rights.”
— Ravi Ragbir, in a press release

ICE response: “U.S. Immigration and Customs Enforcement does not target unlawfully present aliens for arrest based on advocacy positions they hold or in retaliation for critical comments they make. Any suggestion to the contrary is irresponsible, speculative and inaccurate," ICE's Associate Executive Director of Enforcement and Removal Operations Matthew Albence told Axios in a statement. "We will continue to target criminal aliens whenever and however they come to our attention."

Bottom line: "The Plaintiffs' reason for filing the litigation is understandable," Leon Fresco, immigration attorney for Holland & Knight told Axios. However, "the government will have a strong argument that if this litigation is successful, it would create the incentive for every person with potential immigration risk to become an advocate to avoid removal. So it will be important for Plaintiffs to make a carefully crafted argument to refute this point."

The latest: The government has stayed Ragbir's deportation until the briefing and the New York Southern District federal court considers the injunction. Ragbir's lawyers will file for the preliminary injunction on Monday, according to Stanton Jones, a partner at Arnold & Porter law representing the plaintiffs.

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

8 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios